Arkolith/Insider Trading/AGIO/Form 4

Jones Cecilia

Chief Financial OfficerAGIOS PHARMACEUTICALS, INC. (AGIO) · full profile →Form 4 · filed Apr 6, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$109K
Net Open-Market Flow
-$109K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 2, 2026Option exercise(M)9K—$058K
Apr 2, 2026Sell(S)3K$34.71$109K55K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 2, 2026Option exercise(M)9K—$09K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001439222-26-000063) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML